title: Lipid-cytokine-chemokine cascades orchestrate leukocyte recruitment in inflammation.
abstract: Chemoattractants are pivotal mediators of host defense, orchestrating the recruitment of immune cells into sites of infection and inflammation. Chemoattractants display vast chemical diversity and include bioactive lipids, proteolytic fragments of serum proteins, and chemokines (chemotactic cytokines). All chemoattractants induce chemotaxis by activating seven-transmembrane-spanning GPCRs expressed on immune cells, establishing the concept that all chemoattractants are related in function. However, although chemoattractants have overlapping functions in vitro, recent in vivo data have revealed that they function, in many cases, nonredundantly in vivo. The chemically diverse nature of chemoattractants contributes to the fine control of leukocyte trafficking in vivo, with sequential chemoattractant use guiding immune cell recruitment into inflammatory sites. Lipid mediators frequently function as initiators of leukocyte recruitment, attracting the first immune cells into tissues. These initial responding immune cells produce cytokines locally, which in turn, induce the local release of chemokines. Local chemokine production then markedly amplifies subsequent waves of leukocyte recruitment. These new discoveries establish a paradigm for leukocyte recruitment in inflammation--described as lipid-cytokine-chemokine cascades--as a driving force in the effector phase of immune responses.
authors: Division of Rheumatology, Allergy, and Immunology, Massachusetts General Hospital, Harvard Medical School, Boston, MA 02114, USA.
authors: Christian D
authors: CD
authors: Sadik
authors: Andrew D
authors: AD
authors: Luster
mesh_terms: D000818:Animals; D001169:Arthritis, Experimental / Q000503:physiopathology; D001249:Asthma / Q000276:immunology / Q000503:physiopathology; D018925:Chemokines / Q000502:physiology; D002630:Chemotactic Factors / Q000502:physiology*; D002634:Chemotaxis, Leukocyte / Q000502:physiology*; D016207:Cytokines / Q000502:physiology; D005786:Gene Expression Regulation; D006801:Humans; D007249:Inflammation / Q000276:immunology / Q000503:physiopathology*; D018836:Inflammation Mediators / Q000502:physiology*; D007962:Leukocytes / Q000276:immunology / Q000502:physiology*; D007975:Leukotriene B4 / Q000502:physiology; D008055:Lipids / Q000502:physiology; D051379:Mice; D009504:Neutrophils / Q000276:immunology / Q000502:physiology; D043562:Receptors, G-Protein-Coupled / Q000502:physiology; D018102:Receptors, Leukotriene B4 / Q000502:physiology; D015398:Signal Transduction / Q000502:physiology*; D018418:Th2 Cells / Q000276:immunology / Q000378:metabolism
chemical_list: D018925:Chemokines; D002630:Chemotactic Factors; D016207:Cytokines; D018836:Inflammation Mediators; D008055:Lipids; D043562:Receptors, G-Protein-Coupled; D018102:Receptors, Leukotriene B4; D007975:Leukotriene B4